Search

everythinglearnresearchcommunity

for

Search:↓

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

A specific gene mutation is linked to a hereditary form of dystonia that responds well to certain medications.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

Blocking DPP4 can help activate hair growth and improve hair regeneration.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

Progesterone protects rat brain cells by enhancing GABA A receptor activity.

PDGF isoforms can promote and sustain hair growth.

5α-reductase inhibitors, like Finasteride and Dutasteride, help manage benign prostatic hyperplasia.

PRP injection for hair growth can cause reversible vision loss due to inflammatory optic neuropathy.

Higher SRD5A2 expression predicts better response to finasteride in treating urinary symptoms.

The chitosan/PDRN polyplex improved wound healing in diabetic rats.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

Daprodustat, combined with PAβN, could be a new antibacterial treatment.

Finasteride may reduce prostate cancer risk.

Saw palmetto helps with nighttime urination and urine flow, similar to finasteride.

The research gives new understanding on how human steroid 5α-reductases work and how drugs like finasteride inhibit them, which could help in creating new drugs.

Enhanced stem cells from the placenta can help treat Graves' eye disease by stopping fat cell growth.

Combining topical delgocitinib with a 308-nm excimer laser can effectively treat severe alopecia areata and vitiligo.

Some people have a genetic variation that makes them less effective at breaking down drugs.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.